Pharma News

Eisai/Biogen could get FDA verdict on new Alzheimer’s drug by 6 Jan

The US approved the ecstasy test for PTSD

FDA halts tests of Sanofi drug, acquired in $3.7B buyout, due to side effects

FDA Accepts Aflibercept sBLA for Treatment of Diabetic Retinopathy

AstraZeneca Bolsters Blood Cancer Pipeline with $1.27B TeneoTwo Takeover

FDA Recommends Modified COVID-19 Vaccine Boosters Adapted to Omicron BA.4 and BA.5 Subvariants

Sirana Pharma and Pfizer to work on treatment for brittle bone disease

After coeliac fail, 9 Meters plots phase 3 in short bowel syndrome

Dramatic' surprise discovery finds cancer drug delays muscular dystrophy progression in mice

Fast and facile synthesis of antibacterial amino acid Schiff base copper complexes

Protecting the brain from dementia-inducing abnormal protein aggregates

FDA Declines Emergency Use Authorization for ZYESAMI® (aviptadil) for subgroup of Patients with Critical COVID-19 at immediate risk of death from respiratory failure despite treatment with approved therapy, including remdesivir